Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Meningeal Carcinomatosis 7Breast Neoplasms 5Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Glioblastoma 3Astrocytoma 3Neoplastic Cells, Circulating 2Glioma 2Brain Neoplasms 2Oligodendroglioma 1Neoplasm Recurrence, Local 1Meningioma 1Meningeal Neoplasms 1Medulloblastoma 1Lymphoma, Follicular 1

Interventions

Magnetic Resonance Spectroscopy 16Hydroxyurea 7Everolimus 7Bevacizumab 7lutetium Lu 177 dotatate 6gallium Ga 68 dotatate 6Radiosurgery 6Proton Therapy 6Specimen Handling 5pembrolizumab 4Surveys and Questionnaires 4Surgical Procedures, Operative 4Radiotherapy 4Imatinib Mesylate 4Cyclophosphamide 42-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4aldesleukin 3abemaciclib 3Tranexamic Acid 3Temozolomide 3Sunitinib 3Sodium Chloride 3Radiotherapy, Intensity-Modulated 3Observation 3Nivolumab 3Ga(III)-DOTATOC 390Y-octreotide, DOTA-Tyr(3)- 3vistusertib 2trametinib 2ribociclib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningioma × Spinal Puncture × CNS × Clear all
NCT07398170 2026-02-09

BIOLIMEN-1

University Hospital, Montpellier

Phase NA Not yet recruiting
15 enrolled
CNS

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡